246 related articles for article (PubMed ID: 23322330)
1. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
Knežević NŽ; Lin VS
Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
[TBL] [Abstract][Full Text] [Related]
2. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.
Secret E; Smith K; Dubljevic V; Moore E; Macardle P; Delalat B; Rogers ML; Johns TG; Durand JO; Cunin F; Voelcker NH
Adv Healthc Mater; 2013 May; 2(5):718-27. PubMed ID: 23203914
[TBL] [Abstract][Full Text] [Related]
3. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Field-Induced Accentuation of Drug Release from Core/Shell Magnetic Mesoporous Silica Nanoparticles for Anticancer Treatment.
Knezević Nikola Z
J Nanosci Nanotechnol; 2016 Apr; 16(4):4195-9. PubMed ID: 27451786
[TBL] [Abstract][Full Text] [Related]
5. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional hybrid materials for combined photo and chemotherapy of cancer.
Botella P; Ortega I; Quesada M; Madrigal RF; Muniesa C; Fimia A; Fernández E; Corma A
Dalton Trans; 2012 Aug; 41(31):9286-96. PubMed ID: 22555652
[TBL] [Abstract][Full Text] [Related]
7. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract][Full Text] [Related]
8. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
9. Responsive delivery of drug cocktail via mesoporous silica nanolamps.
Muhammad F; Guo M; Wang A; Zhao J; Qi W; Guo Y; Zhu G
J Colloid Interface Sci; 2014 Nov; 434():1-8. PubMed ID: 25151090
[TBL] [Abstract][Full Text] [Related]
10. Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Chen T; Xu S; Zhao T; Zhu L; Wei D; Li Y; Zhang H; Zhao C
ACS Appl Mater Interfaces; 2012 Nov; 4(11):5766-74. PubMed ID: 23043448
[TBL] [Abstract][Full Text] [Related]
11. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
13. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery.
Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y
Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818
[TBL] [Abstract][Full Text] [Related]
14. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform.
Zhang Z; Liu C; Bai J; Wu C; Xiao Y; Li Y; Zheng J; Yang R; Tan W
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6211-9. PubMed ID: 25707533
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
[TBL] [Abstract][Full Text] [Related]
16. Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia.
Lu F; Popa A; Zhou S; Zhu JJ; Samia AC
Chem Commun (Camb); 2013 Dec; 49(97):11436-8. PubMed ID: 24169596
[TBL] [Abstract][Full Text] [Related]
17. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
[TBL] [Abstract][Full Text] [Related]
18. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells.
Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y
J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
